Roche Applied Science Announces CGX Arrays Designed by Signature Genomics for Microarray-based Cytogenetic Analysis
News Nov 09, 2009
Roche Applied Science will announce the European and Asia Pacific launch of the NimbleGen CGX arrays for microarray-based cytogenetic analysis at a workshop series in four European cities and seven cities in Asia Pacific.
The CGX arrays are designed by Signature Genomic Laboratories (Signature Genomics) and provide high-resolution, genome-wide analysis of chromosomal abnormalities.
Roche NimbleGen will provide arrays with the Signature Genomics design in multiplex array formats to accommodate the simultaneous processing and analysis of 3, 6, or 12 samples. The CGX arrays are supported by a comprehensive microarray workflow from Roche that includes NimbleGen reagents and instrumentation. Signature Genomics will offer full support for data analysis using its Genoglyphix® software.
Dr. Lisa G. Shaffer, President and CEO of Signature Genomics and keynote speaker at the workshop events in Europe said, “As one of the pioneers in the field of genomic analysis, we continuously work toward innovation and improvement in the products and services we provide. We feel that the Roche partnership is a synergistic fit between two great organizations. Like us, Roche is focused on technical excellence and delivering valuable and relevant scientific information.”
“We, at Roche, are excited to be partnering with Signature Genomics, the market leader in molecular cytogenetic analysis,” said Dr. Gerd Maass, CEO of Roche NimbleGen. “This collaboration signifies Roche’s incredible progress in the last year towards designing and manufacturing high-quality microarrays with supporting comprehensive workflow solutions that meet the specific needs of researchers in the field of genetic analysis.”
Researchers Awarded $28M for Illuminating Druggable Genome NIH GrantsNews
Researchers receive grants as part of the NIH program focused on experimental and informatics approaches to characterize understudied proteins from three gene families: ion channels, G protein-coupled receptors (GPCRs), and protein kinases.READ MORE
No Country for Old GenesNews
Our modern world is radically different from the one we evolved in, and that creates a mismatch between the environment our genes were evolved to face, and the world those genes now encounter. A new review looks at how certain genes that benefited humans in our genetic past now predispose us to disease in old age.READ MORE
CRISPR Editing Stops HIV Virus in Infected CellsNews
Human immunodeficiency virus-1 (HIV-1) infection is a chronic disease affecting more than 35 million people worldwide. The infection can be controlled by antiretroviral therapy (ART), but there is still no complete cure. Now, a new study targeting the regulatory genes of the virus using CRISPR/Cas9 has helped block the production of the virus by infected cells.READ MORE